An In Vitro Model to Investigate the Role of <i>Helicobacter Pylori</i> in Type 2 Diabetes, Obesity, Alzheimer’s Disease and Cardiometabolic Disease

<i>Helicobacter pylori </i>(<i>Hp</i>) is a Gram-negative bacterium colonizing the human stomach. Nuclear Magnetic Resonance (NMR) analysis of intracellular human gastric carcinoma cells (MKN-28) incubated with the <i>Hp </i>cell filtrate (<i>Hpcf)</i>...

Full description

Bibliographic Details
Main Authors: Paola Cuomo, Marina Papaianni, Clementina Sansone, Antonio Iannelli, Domenico Iannelli, Chiara Medaglia, Debora Paris, Andrea Motta, Rosanna Capparelli
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/21/8369
id doaj-57d381fc6e6447348da97bd496b3bc4f
record_format Article
spelling doaj-57d381fc6e6447348da97bd496b3bc4f2020-11-25T04:07:37ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-11-01218369836910.3390/ijms21218369An In Vitro Model to Investigate the Role of <i>Helicobacter Pylori</i> in Type 2 Diabetes, Obesity, Alzheimer’s Disease and Cardiometabolic DiseasePaola Cuomo0Marina Papaianni1Clementina Sansone2Antonio Iannelli3Domenico Iannelli4Chiara Medaglia5Debora Paris6Andrea Motta7Rosanna Capparelli8Department of Agriculture Sciences, University of Naples “Federico II”, via Università, 100-Portici, 80055 Naples, ItalyDepartment of Agriculture Sciences, University of Naples “Federico II”, via Università, 100-Portici, 80055 Naples, ItalyDepartment of Marine Biotechnology, Stazione Zoologica Anton Dohrn, 80121 Naples, ItalyDepartment of Digestive Surgery, Université Côte d’Azur, Campus Valrose, Batiment L, Avenue de Valrose, 28-CEDEX 2, 06108 Nice, FranceDepartment of Agriculture Sciences, University of Naples “Federico II”, via Università, 100-Portici, 80055 Naples, ItalyDepartment of Microbiology and Molecular Medicine, University of Geneva Medical School, rue du Général-Dufour, Genève 1211, SwitzerlandInstitute of Biomolecular Chemistry, National Research Council, via Campi Flegrei, 34-Pozzuoli, 80078 Naples, ItalyInstitute of Biomolecular Chemistry, National Research Council, via Campi Flegrei, 34-Pozzuoli, 80078 Naples, ItalyDepartment of Agriculture Sciences, University of Naples “Federico II”, via Università, 100-Portici, 80055 Naples, Italy<i>Helicobacter pylori </i>(<i>Hp</i>) is a Gram-negative bacterium colonizing the human stomach. Nuclear Magnetic Resonance (NMR) analysis of intracellular human gastric carcinoma cells (MKN-28) incubated with the <i>Hp </i>cell filtrate (<i>Hpcf)</i> displays high levels of amino acids, including the branched chain amino acids (BCAA) isoleucine<b>,</b> leucine, and valine. Polymerase chain reaction (PCR) Array Technology shows upregulation of mammalian Target Of Rapamycin Complex 1 (mTORC1), inflammation, and mitochondrial dysfunction. The review of literature indicates that these traits are common to type 2 diabetes, obesity, Alzheimer’s diseases, and cardiometabolic disease. Here, we demonstrate how <i>Hp</i> may modulate these traits. <i>Hp</i> induces high levels of amino acids, which, in turn, activate mTORC1, which is the complex regulating the metabolism of the host. A high level of BCAA and upregulation of mTORC1 are, thus, directly regulated by <i>Hp</i>. Furthermore, <i>Hp </i>modulates inflammation, which is functional to the persistence of chronic infection and the asymptomatic state of the host. Finally, in order to induce autophagy and sustain bacterial colonization of gastric mucosa, the <i>Hp </i>toxin VacA localizes within mitochondria, causing fragmentation of these organelles, depletion of ATP, and oxidative stress. In conclusion, our in vitro disease model replicates the main traits common to the above four diseases and shows how <i>Hp</i> may potentially manipulate them.https://www.mdpi.com/1422-0067/21/21/8369Helicobacter pylorimTORC1branched chain amino acidsinflammationmitochondrial dysfunction
collection DOAJ
language English
format Article
sources DOAJ
author Paola Cuomo
Marina Papaianni
Clementina Sansone
Antonio Iannelli
Domenico Iannelli
Chiara Medaglia
Debora Paris
Andrea Motta
Rosanna Capparelli
spellingShingle Paola Cuomo
Marina Papaianni
Clementina Sansone
Antonio Iannelli
Domenico Iannelli
Chiara Medaglia
Debora Paris
Andrea Motta
Rosanna Capparelli
An In Vitro Model to Investigate the Role of <i>Helicobacter Pylori</i> in Type 2 Diabetes, Obesity, Alzheimer’s Disease and Cardiometabolic Disease
International Journal of Molecular Sciences
Helicobacter pylori
mTORC1
branched chain amino acids
inflammation
mitochondrial dysfunction
author_facet Paola Cuomo
Marina Papaianni
Clementina Sansone
Antonio Iannelli
Domenico Iannelli
Chiara Medaglia
Debora Paris
Andrea Motta
Rosanna Capparelli
author_sort Paola Cuomo
title An In Vitro Model to Investigate the Role of <i>Helicobacter Pylori</i> in Type 2 Diabetes, Obesity, Alzheimer’s Disease and Cardiometabolic Disease
title_short An In Vitro Model to Investigate the Role of <i>Helicobacter Pylori</i> in Type 2 Diabetes, Obesity, Alzheimer’s Disease and Cardiometabolic Disease
title_full An In Vitro Model to Investigate the Role of <i>Helicobacter Pylori</i> in Type 2 Diabetes, Obesity, Alzheimer’s Disease and Cardiometabolic Disease
title_fullStr An In Vitro Model to Investigate the Role of <i>Helicobacter Pylori</i> in Type 2 Diabetes, Obesity, Alzheimer’s Disease and Cardiometabolic Disease
title_full_unstemmed An In Vitro Model to Investigate the Role of <i>Helicobacter Pylori</i> in Type 2 Diabetes, Obesity, Alzheimer’s Disease and Cardiometabolic Disease
title_sort in vitro model to investigate the role of <i>helicobacter pylori</i> in type 2 diabetes, obesity, alzheimer’s disease and cardiometabolic disease
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2020-11-01
description <i>Helicobacter pylori </i>(<i>Hp</i>) is a Gram-negative bacterium colonizing the human stomach. Nuclear Magnetic Resonance (NMR) analysis of intracellular human gastric carcinoma cells (MKN-28) incubated with the <i>Hp </i>cell filtrate (<i>Hpcf)</i> displays high levels of amino acids, including the branched chain amino acids (BCAA) isoleucine<b>,</b> leucine, and valine. Polymerase chain reaction (PCR) Array Technology shows upregulation of mammalian Target Of Rapamycin Complex 1 (mTORC1), inflammation, and mitochondrial dysfunction. The review of literature indicates that these traits are common to type 2 diabetes, obesity, Alzheimer’s diseases, and cardiometabolic disease. Here, we demonstrate how <i>Hp</i> may modulate these traits. <i>Hp</i> induces high levels of amino acids, which, in turn, activate mTORC1, which is the complex regulating the metabolism of the host. A high level of BCAA and upregulation of mTORC1 are, thus, directly regulated by <i>Hp</i>. Furthermore, <i>Hp </i>modulates inflammation, which is functional to the persistence of chronic infection and the asymptomatic state of the host. Finally, in order to induce autophagy and sustain bacterial colonization of gastric mucosa, the <i>Hp </i>toxin VacA localizes within mitochondria, causing fragmentation of these organelles, depletion of ATP, and oxidative stress. In conclusion, our in vitro disease model replicates the main traits common to the above four diseases and shows how <i>Hp</i> may potentially manipulate them.
topic Helicobacter pylori
mTORC1
branched chain amino acids
inflammation
mitochondrial dysfunction
url https://www.mdpi.com/1422-0067/21/21/8369
work_keys_str_mv AT paolacuomo aninvitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
AT marinapapaianni aninvitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
AT clementinasansone aninvitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
AT antonioiannelli aninvitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
AT domenicoiannelli aninvitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
AT chiaramedaglia aninvitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
AT deboraparis aninvitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
AT andreamotta aninvitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
AT rosannacapparelli aninvitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
AT paolacuomo invitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
AT marinapapaianni invitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
AT clementinasansone invitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
AT antonioiannelli invitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
AT domenicoiannelli invitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
AT chiaramedaglia invitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
AT deboraparis invitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
AT andreamotta invitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
AT rosannacapparelli invitromodeltoinvestigatetheroleofihelicobacterpyloriiintype2diabetesobesityalzheimersdiseaseandcardiometabolicdisease
_version_ 1724428190217142272